Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viraemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00006145
What this trial is testing

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 350
Not applicableStudy completedNCT00050063
What this trial is testing

Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 78
Early research (Phase 1)WithdrawnNCT01909414
What this trial is testing

Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Looking for participantsNCT06059391
What this trial is testing

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
City of Hope Medical Center 216
Testing effectiveness (Phase 2)Study completedNCT00515827
What this trial is testing

Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 53
Testing effectiveness (Phase 2)Study completedNCT00442169
What this trial is testing

Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults

Who this might be right for
West Nile Fever
Sanofi Pasteur, a Sanofi Company 208
Post-approval studies (Phase 4)Ended earlyNCT00855413
What this trial is testing

HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine

Who this might be right for
Acute HIV InfectionHIV Infections
University of North Carolina, Chapel Hill 15
Early research (Phase 1)Study completedNCT02652546
What this trial is testing

CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)

Who this might be right for
HIV, Inflammation
National Institute of Allergy and Infectious Diseases (NIAID) 38
Not applicableLooking for participantsNCT07085611
What this trial is testing

Neutralizing Power of Serum Antibodies - 2

Who this might be right for
COVID-19SARS-CoV-2 ViraemiaMonkey Pox+3 more
Centre Hospitalier Régional d'Orléans 30
Large-scale testing (Phase 3)Study completedNCT00025909
What this trial is testing

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 90
Post-approval studies (Phase 4)UnknownNCT05799716
What this trial is testing

Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections

Who this might be right for
ViremiaBacteremiaAcute Rejection of Renal Transplant
Shanghai Changzheng Hospital 40
Post-approval studies (Phase 4)Study completedNCT03382847
What this trial is testing

HCV Positive Heart Donors

Who this might be right for
Heart Failure
NYU Langone Health 25
Testing effectiveness (Phase 2)Study completedNCT00000848
What this trial is testing

The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 144
Large-scale testing (Phase 3)Study completedNCT00160329
What this trial is testing

Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia

Who this might be right for
HyperlipidemiaHIV Infections
Stanford University 60
Not applicableUnknownNCT04298502
What this trial is testing

The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human

Who this might be right for
Acute LeukemiaCMV ViremiaHematopoietic Stem Cell Transplantation
Peking University People's Hospital 40
Not applicableUnknownNCT02354209
What this trial is testing

Targeted Clinical Strategies and Low Level Viraemia (LLV) in Boosted Protease Inhibitor Therapy

Who this might be right for
HIV
St Stephens Aids Trust 50
Testing effectiveness (Phase 2)Study completedNCT01498484
What this trial is testing

Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From a Normal HLA-Compatible Or Partially-Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies

Who this might be right for
EBV-induced LymphomasEBV-associated MalignanciesTransplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV Lymphoma
Atara Biotherapeutics 87
Post-approval studies (Phase 4)Ended earlyNCT00414284
What this trial is testing

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

Who this might be right for
HIV Infections
Community Research Initiative of New England
Large-scale testing (Phase 3)Study completedNCT00051038
What this trial is testing

Study of Adding Entecavir to Current Lamivudine Therapy in HIV and HBV Co-Infected Patients

Who this might be right for
Hepatitis B
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00002268
What this trial is testing

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Sandoz
Next Page